奎斯特診斷公司

出自 MBA智库百科(https://wiki.mbalib.com/)

本條目包含過多不是中文的內容，歡迎協助翻譯。 若已有相當內容譯為中文，可逕自去除本模板。

奎斯特診斷公司（Quest Diagnostics）

奎斯特診斷公司官方網站網址：http://www.questdiagnostics.com/ 英文

　　奎斯特診斷公司（Quest Diagnostics）是美國最大的臨床診斷公司，也是是著名的生化醫療器材測試商。這家公司發起於1967年，期間經歷多次併購，1996年在美國紐交所上市。Quest在美國擁有31個區域性大型診斷中心，155家快速反應實驗室，超過2100個病人服務中心，每年診斷超過1億個標本。

　　奎斯特診斷公司為健康護理專業人員提供專業知識，協助他們做出正確診斷，來改善病患的健康狀況。這家公司透過所屬的實驗室和病患服務中心，為美國地區的民眾提供診斷測試服務，並透過其人數眾多的醫療和科學員工提供詳盡的咨詢服務。

　　目前，美國前三名公司的市場占有率超過60％，市場集中度很高。在歐美和日本等發達國家，獨立實驗室已經占據臨床檢驗市場的1/3。而中國99％的檢驗業務仍在醫院檢驗科完成。但相比Quest擁有的3000多項檢驗項目，中國的大型醫院也只有500—1000個項目。2006年收入63億美元。

　　Quest Diagnostics Incorporated (NYSE: DGX) is a United States corporation which provides clinical laboratory services. The company has operations in the United States, United Kingdom, Mexico and through its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd, a laboratory in India^[1] in addition to service locations located in Brazil. Quest Diagnostics also has collaborative agreements internationally with various hospitals and clinics.^[2] Quest Diagnostics also has operations in the US Territory of Puerto Rico.^[3]

　　Quest Diagnostics is a member of the Fortune 500 and the S&P 500. The company's corporate headquarters were previously located in Teterboro, New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in Madison, New Jersey^[4] having moved there in October 2007 from Lyndhurst, New Jersey.

• 1967: Founded by Paul A. Brown, MD as Metropolitan Pathology Laboratory, Inc., in New York.
• 1969: Name Changed to MetPath, Inc., in Teaneck, New Jersey.
• 1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
• 1997: Quest Diagnostics becomes an independent company as a spin-off from Corning.
• 1997: Acquires clinical laboratory division of Branford, CT-based Diagnostic Medical Laboratory, Inc. (DML)^[5].
• 1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock. The SmithKline Beecham acquisition includes a joint venture ownership with CompuNet Clinical Laboratory
• 2000: Launch of Six Sigma program leading the charge to raise the quality of healthcare delivery in the United States.
• 2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
• 2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
• 2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
• 2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS) for approximately $934 million.
• 2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
• 2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
• 2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.
• 2007: Acquires AmeriPath, becoming the leading provider of cancer diagnostic testing services.
• 2010: Laid off 70 percent of processor's in Lenexa and have cut costs and employee overtime due to decline of clients, poor sales and poor managment.